AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

OCTOBER 5, 2023

We are pleased to present these results from the LIGHTHOUSE study to the radiation oncology community at ASTRO,” said David E. Chief Executive Officer of Blue Earth Diagnostics. The findings were discussed in a poster Q&A session at the 2023 ASTRO Annual Meeting on October 3, 2023 ,“ Diagnostic Performance of 18 F-rhPSMA-7.3

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52